| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 2.97e-07 | 4 | 85 | 3 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 2.97e-07 | 4 | 85 | 3 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 2.97e-07 | 4 | 85 | 3 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 7.40e-07 | 5 | 85 | 3 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 7.40e-07 | 5 | 85 | 3 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 7.40e-07 | 5 | 85 | 3 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 7.40e-07 | 5 | 85 | 3 | GO:0047006 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 7.40e-07 | 5 | 85 | 3 | GO:0047787 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 7.40e-07 | 5 | 85 | 3 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 7.40e-07 | 5 | 85 | 3 | GO:0047086 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.48e-06 | 6 | 85 | 3 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 2.57e-06 | 7 | 85 | 3 | GO:0072582 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 | 3.94e-06 | 1244 | 85 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 4.11e-06 | 8 | 85 | 3 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 4.11e-06 | 8 | 85 | 3 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 4.11e-06 | 8 | 85 | 3 | GO:0035671 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 | 5.31e-06 | 1271 | 85 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 5.80e-06 | 1412 | 85 | 19 | GO:0000981 |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 6.14e-06 | 9 | 85 | 3 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 6.14e-06 | 9 | 85 | 3 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 8.74e-06 | 10 | 85 | 3 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 8.74e-06 | 10 | 85 | 3 | GO:0032052 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 9.28e-06 | 1459 | 85 | 19 | GO:0000977 |
| GeneOntologyMolecularFunction | GTPase activity | 1.46e-05 | 341 | 85 | 9 | GO:0003924 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RGS8 RGS18 ABCA13 EIF4A3 MLH1 MFN2 NLRP1 GNAO1 RAB5A RGS2 RGS3 RGS10 MFN1 | 2.29e-05 | 775 | 85 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 2.62e-05 | 14 | 85 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 2.62e-05 | 14 | 85 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 3.32e-05 | 43 | 85 | 4 | GO:0001965 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RGS8 RGS18 ABCA13 EIF4A3 MLH1 MFN2 NLRP1 GNAO1 RAB5A RGS2 RGS3 RGS10 MFN1 | 5.21e-05 | 839 | 85 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RGS8 RGS18 ABCA13 EIF4A3 MLH1 MFN2 NLRP1 GNAO1 RAB5A RGS2 RGS3 RGS10 MFN1 | 5.27e-05 | 840 | 85 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RGS8 RGS18 ABCA13 EIF4A3 MLH1 MFN2 NLRP1 GNAO1 RAB5A RGS2 RGS3 RGS10 MFN1 | 5.27e-05 | 840 | 85 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 8.05e-05 | 20 | 85 | 3 | GO:0004303 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.07e-04 | 4 | 85 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 1.07e-04 | 4 | 85 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | guanine/thymine mispair binding | 1.07e-04 | 4 | 85 | 2 | GO:0032137 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.41e-04 | 24 | 85 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.80e-04 | 26 | 85 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 1.80e-04 | 26 | 85 | 3 | GO:0070402 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.88e-04 | 279 | 85 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.02e-04 | 27 | 85 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 2.78e-04 | 30 | 85 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 3.38e-04 | 32 | 85 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.70e-04 | 33 | 85 | 3 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 4.05e-04 | 34 | 85 | 3 | GO:0016628 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.48e-04 | 230 | 85 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 5.64e-04 | 38 | 85 | 3 | GO:0000146 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 6.09e-04 | 39 | 85 | 3 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 6.56e-04 | 40 | 85 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 8.12e-04 | 43 | 85 | 3 | GO:0008307 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 9.61e-04 | 11 | 85 | 2 | GO:0030283 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 9.61e-04 | 11 | 85 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.12e-03 | 48 | 85 | 3 | GO:0016620 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.13e-03 | 107 | 85 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.19e-03 | 614 | 85 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.42e-03 | 507 | 85 | 8 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.42e-03 | 507 | 85 | 8 | GO:0030695 | |
| GeneOntologyMolecularFunction | mismatched DNA binding | 1.58e-03 | 14 | 85 | 2 | GO:0030983 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.75e-03 | 56 | 85 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 1.88e-03 | 656 | 85 | 9 | GO:0008047 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 2.14e-03 | 60 | 85 | 3 | GO:0016655 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 2.35e-03 | 62 | 85 | 3 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 2.35e-03 | 62 | 85 | 3 | GO:0050661 | |
| GeneOntologyMolecularFunction | ATP-dependent DNA damage sensor activity | 3.24e-03 | 20 | 85 | 2 | GO:0140664 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 3.55e-03 | 239 | 85 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.57e-03 | 21 | 85 | 2 | GO:0035613 | |
| GeneOntologyMolecularFunction | organic acid binding | 4.60e-03 | 254 | 85 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | DNA damage sensor activity | 4.65e-03 | 24 | 85 | 2 | GO:0140612 | |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 5.04e-03 | 25 | 85 | 2 | GO:0048027 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 7.78e-03 | 95 | 85 | 3 | GO:0016651 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 9.49e-03 | 194 | 85 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 1.08e-02 | 37 | 85 | 2 | GO:0042923 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 2.69e-07 | 4 | 85 | 3 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 2.69e-07 | 4 | 85 | 3 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 2.69e-07 | 4 | 85 | 3 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 2.69e-07 | 4 | 85 | 3 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 6.71e-07 | 5 | 85 | 3 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 6.71e-07 | 5 | 85 | 3 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 6.71e-07 | 5 | 85 | 3 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 6.71e-07 | 5 | 85 | 3 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 6.71e-07 | 5 | 85 | 3 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 6.71e-07 | 5 | 85 | 3 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.34e-06 | 6 | 85 | 3 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.34e-06 | 6 | 85 | 3 | GO:0016095 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 2.24e-06 | 23 | 85 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 2.34e-06 | 7 | 85 | 3 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 2.34e-06 | 7 | 85 | 3 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 2.34e-06 | 7 | 85 | 3 | GO:1900052 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 5.57e-06 | 9 | 85 | 3 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 7.94e-06 | 10 | 85 | 3 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 7.94e-06 | 10 | 85 | 3 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 7.94e-06 | 10 | 85 | 3 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 7.94e-06 | 10 | 85 | 3 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 7.94e-06 | 10 | 85 | 3 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.09e-05 | 11 | 85 | 3 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.09e-05 | 11 | 85 | 3 | GO:0016115 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 1.43e-05 | 36 | 85 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 2.38e-05 | 14 | 85 | 3 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 2.38e-05 | 14 | 85 | 3 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 2.97e-05 | 15 | 85 | 3 | GO:0016102 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 3.34e-05 | 89 | 85 | 5 | GO:2000379 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 3.34e-05 | 89 | 85 | 5 | GO:0055002 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 3.64e-05 | 16 | 85 | 3 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 3.64e-05 | 16 | 85 | 3 | GO:0032351 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 5.27e-05 | 18 | 85 | 3 | GO:0030656 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 8.51e-05 | 21 | 85 | 3 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 8.51e-05 | 21 | 85 | 3 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 8.51e-05 | 21 | 85 | 3 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 8.51e-05 | 21 | 85 | 3 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 8.51e-05 | 21 | 85 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | parturition | 9.83e-05 | 22 | 85 | 3 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 9.83e-05 | 22 | 85 | 3 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 9.83e-05 | 22 | 85 | 3 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 9.83e-05 | 22 | 85 | 3 | GO:1902644 | |
| GeneOntologyBiologicalProcess | regulation of G protein-coupled receptor signaling pathway | 1.04e-04 | 181 | 85 | 6 | GO:0008277 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 1.13e-04 | 23 | 85 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | NPY4R2 RGS8 RGS18 IGF2R LPAR5 NPY4R P2RY4 DGKK BECN2 AKR1C3 GNAO1 RGS2 AKR1C1 RGS3 AKR1C2 RGS10 | 1.62e-04 | 1395 | 85 | 16 | GO:0007186 |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 1.64e-04 | 26 | 85 | 3 | GO:0010566 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 1.89e-04 | 69 | 85 | 4 | GO:0070542 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.95e-04 | 129 | 85 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 2.02e-04 | 130 | 85 | 5 | GO:0097306 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 2.05e-04 | 28 | 85 | 3 | GO:0048025 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 2.28e-04 | 29 | 85 | 3 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 2.28e-04 | 29 | 85 | 3 | GO:0050686 | |
| GeneOntologyBiologicalProcess | muscle contraction | 2.44e-04 | 400 | 85 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | response to alcohol | 3.05e-04 | 312 | 85 | 7 | GO:0097305 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 3.07e-04 | 32 | 85 | 3 | GO:2000353 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 3.37e-04 | 33 | 85 | 3 | GO:0033119 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 3.69e-04 | 34 | 85 | 3 | GO:0006706 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 4.02e-04 | 35 | 85 | 3 | GO:0120255 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 4.37e-04 | 36 | 85 | 3 | GO:0008299 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 4.41e-04 | 86 | 85 | 4 | GO:0030239 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial fission | 4.62e-04 | 8 | 85 | 2 | GO:0090258 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 4.82e-04 | 443 | 85 | 8 | GO:1903311 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 4.96e-04 | 158 | 85 | 5 | GO:0050684 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 5.13e-04 | 38 | 85 | 3 | GO:0048384 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 5.98e-04 | 40 | 85 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 6.90e-04 | 42 | 85 | 3 | GO:0071398 | |
| GeneOntologyBiologicalProcess | muscle cell development | 7.07e-04 | 259 | 85 | 6 | GO:0055001 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 8.46e-04 | 45 | 85 | 3 | GO:0008207 | |
| GeneOntologyBiologicalProcess | translational readthrough | 9.01e-04 | 11 | 85 | 2 | GO:0006451 | |
| GeneOntologyBiologicalProcess | selenocysteine incorporation | 9.01e-04 | 11 | 85 | 2 | GO:0001514 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 9.61e-04 | 47 | 85 | 3 | GO:0046164 | |
| GeneOntologyBiologicalProcess | intracellular distribution of mitochondria | 1.08e-03 | 12 | 85 | 2 | GO:0048312 | |
| GeneOntologyBiologicalProcess | regulation of reactive oxygen species metabolic process | 1.09e-03 | 188 | 85 | 5 | GO:2000377 | |
| GeneOntologyBiologicalProcess | reactive oxygen species metabolic process | 1.29e-03 | 291 | 85 | 6 | GO:0072593 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.31e-03 | 115 | 85 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | ADGB CNTD1 NLRP14 IGF2R PIK3CA SLC22A5 MLH1 ZNF429 MFN2 CFAP61 WDR77 RGS2 ZNF595 | 1.57e-03 | 1235 | 85 | 13 | GO:0003006 |
| GeneOntologyBiologicalProcess | autophagosome assembly | 1.58e-03 | 121 | 85 | 4 | GO:0000045 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 1.60e-03 | 56 | 85 | 3 | GO:0006693 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.66e-03 | 207 | 85 | 5 | GO:0043484 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 1.68e-03 | 57 | 85 | 3 | GO:0006692 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 1.68e-03 | 57 | 85 | 3 | GO:0042181 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 1.77e-03 | 58 | 85 | 3 | GO:0032350 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.87e-03 | 547 | 85 | 8 | GO:0003012 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane potential | 1.94e-03 | 16 | 85 | 2 | GO:0010918 | |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 1.94e-03 | 128 | 85 | 4 | GO:0007265 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 1.95e-03 | 60 | 85 | 3 | GO:1904037 | |
| GeneOntologyBiologicalProcess | autophagosome organization | 2.00e-03 | 129 | 85 | 4 | GO:1905037 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 2.06e-03 | 130 | 85 | 4 | GO:1901655 | |
| GeneOntologyBiologicalProcess | somatic hypermutation of immunoglobulin genes | 2.19e-03 | 17 | 85 | 2 | GO:0016446 | |
| GeneOntologyCellularComponent | myosin filament | 3.02e-06 | 25 | 85 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II filament | 4.89e-05 | 3 | 85 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | myosin II complex | 1.97e-04 | 28 | 85 | 3 | GO:0016460 | |
| MousePheno | parturition failure | 1.02e-05 | 10 | 63 | 3 | MP:0012010 | |
| MousePheno | hypermyelination | 1.40e-05 | 11 | 63 | 3 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 2.42e-05 | 13 | 63 | 3 | MP:0010160 | |
| MousePheno | enhanced coordination | 2.46e-05 | 38 | 63 | 4 | MP:0003858 | |
| MousePheno | abnormal stride length | 3.31e-05 | 82 | 63 | 5 | MP:0012690 | |
| MousePheno | increased circulating progesterone level | 3.82e-05 | 15 | 63 | 3 | MP:0005186 | |
| MousePheno | long stride length | 3.82e-05 | 15 | 63 | 3 | MP:0010540 | |
| MousePheno | long gestation period | 3.82e-05 | 15 | 63 | 3 | MP:0002293 | |
| MousePheno | abnormal gestational length | 6.78e-05 | 18 | 63 | 3 | MP:0002292 | |
| MousePheno | dysmyelination | 9.42e-05 | 20 | 63 | 3 | MP:0013438 | |
| MousePheno | decreased oligodendrocyte number | 1.87e-04 | 25 | 63 | 3 | MP:0009808 | |
| MousePheno | abnormal atrioventricular valve development | 1.98e-04 | 5 | 63 | 2 | MP:0031550 | |
| MousePheno | maternal imprinting | 2.64e-04 | 28 | 63 | 3 | MP:0003122 | |
| MousePheno | abnormal corticotroph morphology | 2.96e-04 | 6 | 63 | 2 | MP:0008327 | |
| MousePheno | prolonged diestrus | 3.25e-04 | 30 | 63 | 3 | MP:0009011 | |
| MousePheno | abnormal parturition | 4.32e-04 | 33 | 63 | 3 | MP:0002907 | |
| Domain | KRAB | ZNF141 ZNF732 ZNF718 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 2.99e-14 | 358 | 85 | 18 | PS50805 |
| Domain | KRAB | ZNF141 ZNF732 ZNF718 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 2.99e-14 | 358 | 85 | 18 | PF01352 |
| Domain | KRAB | ZNF141 ZNF732 ZNF718 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 5.03e-14 | 369 | 85 | 18 | SM00349 |
| Domain | KRAB | ZNF141 ZNF732 ZNF718 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 5.27e-14 | 370 | 85 | 18 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF141 ZNF732 ZNF718 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 | 1.40e-10 | 314 | 85 | 14 | PF13912 |
| Domain | zf-C2H2 | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 2.21e-10 | 693 | 85 | 19 | PF00096 |
| Domain | - | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF441 | 1.22e-09 | 679 | 85 | 18 | 3.30.160.60 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 1.43e-09 | 775 | 85 | 19 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 1.49e-09 | 777 | 85 | 19 | PS00028 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF441 | 1.72e-09 | 694 | 85 | 18 | IPR013087 |
| Domain | Znf_C2H2 | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 2.67e-09 | 805 | 85 | 19 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 2.84e-09 | 808 | 85 | 19 | SM00355 |
| Domain | Znf_C2H2-like | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF441 | 1.46e-08 | 796 | 85 | 18 | IPR015880 |
| Domain | - | 4.29e-08 | 22 | 85 | 5 | 1.10.196.10 | |
| Domain | RGS_subdom1 | 4.29e-08 | 22 | 85 | 5 | IPR024066 | |
| Domain | RGS | 5.05e-07 | 35 | 85 | 5 | PF00615 | |
| Domain | RGS | 5.05e-07 | 35 | 85 | 5 | SM00315 | |
| Domain | RGS | 5.85e-07 | 36 | 85 | 5 | PS50132 | |
| Domain | RGS | 8.84e-07 | 39 | 85 | 5 | IPR016137 | |
| Domain | P-loop_NTPase | PSTK MYH10 MYH11 NLRP14 SPATA17 MYH14 ABCA13 EIF4A3 MFN2 NLRP1 MSH3 GNAO1 DSEL RAB5A MFN1 | 5.84e-06 | 848 | 85 | 15 | IPR027417 |
| Domain | ALDOKETO_REDUCTASE_1 | 1.07e-05 | 10 | 85 | 3 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 1.07e-05 | 10 | 85 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.07e-05 | 10 | 85 | 3 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.07e-05 | 10 | 85 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.07e-05 | 10 | 85 | 3 | PS00063 | |
| Domain | Mitofusin_fam | 2.05e-05 | 2 | 85 | 2 | IPR027094 | |
| Domain | NPY4_rcpt | 2.05e-05 | 2 | 85 | 2 | IPR001933 | |
| Domain | Fzo_mitofusin | 2.05e-05 | 2 | 85 | 2 | PF04799 | |
| Domain | Fzo/mitofusin_HR2 | 2.05e-05 | 2 | 85 | 2 | IPR006884 | |
| Domain | IQ | 3.39e-05 | 81 | 85 | 5 | SM00015 | |
| Domain | Myosin_N | 3.98e-05 | 15 | 85 | 3 | PF02736 | |
| Domain | Myosin_N | 3.98e-05 | 15 | 85 | 3 | IPR004009 | |
| Domain | - | 4.88e-05 | 16 | 85 | 3 | 3.20.20.100 | |
| Domain | IQ_motif_EF-hand-BS | 5.62e-05 | 90 | 85 | 5 | IPR000048 | |
| Domain | NADP_OxRdtase_dom | 5.91e-05 | 17 | 85 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 5.91e-05 | 17 | 85 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 5.91e-05 | 17 | 85 | 3 | IPR001395 | |
| Domain | IQ | 6.58e-05 | 93 | 85 | 5 | PS50096 | |
| Domain | Myosin_tail_1 | 7.07e-05 | 18 | 85 | 3 | PF01576 | |
| Domain | Myosin_tail | 7.07e-05 | 18 | 85 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 8.36e-05 | 19 | 85 | 3 | IPR027401 | |
| Domain | - | 8.36e-05 | 19 | 85 | 3 | 4.10.270.10 | |
| Domain | Myosin_S1_N | 2.03e-04 | 5 | 85 | 2 | IPR008989 | |
| Domain | IQ | 3.08e-04 | 71 | 85 | 4 | PF00612 | |
| Domain | - | PSTK NLRP14 ABCA13 EIF4A3 MFN2 NLRP1 MSH3 GNAO1 DSEL RAB5A MFN1 | 5.54e-04 | 746 | 85 | 11 | 3.40.50.300 |
| Domain | Myosin_head_motor_dom | 6.84e-04 | 38 | 85 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 6.84e-04 | 38 | 85 | 3 | PS51456 | |
| Domain | Myosin_head | 6.84e-04 | 38 | 85 | 3 | PF00063 | |
| Domain | MYSc | 6.84e-04 | 38 | 85 | 3 | SM00242 | |
| Domain | NPY_rcpt | 7.22e-04 | 9 | 85 | 2 | IPR000611 | |
| Domain | G_DYNAMIN_dom | 1.80e-03 | 14 | 85 | 2 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 1.80e-03 | 14 | 85 | 2 | PS51718 | |
| Domain | Dynamin_GTPase | 2.07e-03 | 15 | 85 | 2 | IPR001401 | |
| Domain | Dynamin_N | 2.07e-03 | 15 | 85 | 2 | PF00350 | |
| Domain | Dynamin_SF | 2.07e-03 | 15 | 85 | 2 | IPR022812 | |
| Domain | DAPIN | 4.46e-03 | 22 | 85 | 2 | PS50824 | |
| Domain | PYRIN | 4.46e-03 | 22 | 85 | 2 | PF02758 | |
| Domain | DAPIN | 4.46e-03 | 22 | 85 | 2 | IPR004020 | |
| Domain | PYRIN | 4.46e-03 | 22 | 85 | 2 | SM01289 | |
| Domain | NACHT | 4.87e-03 | 23 | 85 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 4.87e-03 | 23 | 85 | 2 | IPR007111 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.14e-05 | 9 | 74 | 3 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 1.14e-05 | 9 | 74 | 3 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 2.22e-05 | 11 | 74 | 3 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 3.82e-05 | 13 | 74 | 3 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 3.82e-05 | 13 | 74 | 3 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 4.85e-05 | 14 | 74 | 3 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 4.85e-05 | 14 | 74 | 3 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 4.85e-05 | 14 | 74 | 3 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 4.85e-05 | 14 | 74 | 3 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 6.04e-05 | 15 | 74 | 3 | MM14870 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.27e-04 | 19 | 74 | 3 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 1.27e-04 | 19 | 74 | 3 | M27489 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.48e-04 | 20 | 74 | 3 | M18415 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.73e-04 | 21 | 74 | 3 | M27494 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 2.28e-04 | 23 | 74 | 3 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.28e-04 | 23 | 74 | 3 | MM16639 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 2.28e-04 | 23 | 74 | 3 | MM15222 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 2.28e-04 | 23 | 74 | 3 | MM14741 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF141 TP53INP1 ZNF732 ZNF718 ZNF665 EIF4A3 ZNF92 ZNF540 ZNF611 MLH1 ZNF195 ZNF429 ZNF480 ZNF701 ZNF860 ZNF519 ZNF595 ZNF441 | 2.29e-04 | 1387 | 74 | 18 | M734 |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 2.60e-04 | 24 | 74 | 3 | M2243 | |
| Pathway | REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR | 2.69e-04 | 5 | 74 | 2 | M27448 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 3.50e-04 | 64 | 74 | 4 | M7923 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 4.14e-04 | 28 | 74 | 3 | MM15188 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 4.60e-04 | 29 | 74 | 3 | M27309 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 4.94e-04 | 70 | 74 | 4 | M12294 | |
| Pathway | REACTOME_MIRO_GTPASE_CYCLE | 5.61e-04 | 7 | 74 | 2 | MM15689 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 6.77e-04 | 33 | 74 | 3 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 6.77e-04 | 33 | 74 | 3 | MM14737 | |
| Pathway | REACTOME_MIRO_GTPASE_CYCLE | 7.46e-04 | 8 | 74 | 2 | M41837 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 8.12e-04 | 210 | 74 | 6 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 9.62e-04 | 217 | 74 | 6 | M18437 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | RGS8 RGS18 LPAR5 NPY4R P2RY4 PIK3CA DGKK RGS2 RGS3 RGS10 SOS2 | 1.03e-03 | 702 | 74 | 11 | M746 |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.04e-03 | 147 | 74 | 5 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.17e-03 | 151 | 74 | 5 | M39329 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.28e-03 | 314 | 74 | 7 | M600 | |
| Pathway | REACTOME_TBC_RABGAPS | 1.58e-03 | 44 | 74 | 3 | M27748 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.58e-03 | 44 | 74 | 3 | M499 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 1.68e-03 | 45 | 74 | 3 | M39355 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.68e-03 | 45 | 74 | 3 | MM15344 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.68e-03 | 45 | 74 | 3 | MM14751 | |
| Pathway | REACTOME_Z_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_ZYGOTICALLY_EXPRESSED_FACTORS | 1.73e-03 | 12 | 74 | 2 | M48027 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 1.93e-03 | 646 | 74 | 10 | MM14962 | |
| Pathway | WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION | 2.04e-03 | 13 | 74 | 2 | M48341 | |
| Pubmed | 4.68e-10 | 17 | 85 | 5 | 20627871 | ||
| Pubmed | ZNF718 ZNF92 ZNF611 ZNF195 ZNF480 ZNF766 ZNF701 ZNF595 ZNF441 | 6.72e-10 | 181 | 85 | 9 | 37372979 | |
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 5.99e-09 | 27 | 85 | 5 | 14581517 | |
| Pubmed | 8.78e-09 | 29 | 85 | 5 | 14563677 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 1.41e-08 | 3 | 85 | 3 | 31780644 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 21232532 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 13678667 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 20124700 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 5.63e-08 | 4 | 85 | 3 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 5.63e-08 | 4 | 85 | 3 | 16508162 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 5.63e-08 | 4 | 85 | 3 | 14967952 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 5.63e-08 | 4 | 85 | 3 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 5.63e-08 | 4 | 85 | 3 | 31479646 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 15222881 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 16191478 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 15577209 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 10702227 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 17034817 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 17629694 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 5.63e-08 | 4 | 85 | 3 | 29764944 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 10526179 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 17888864 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 17442338 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 28329705 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 16018803 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 17272929 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 5.63e-08 | 4 | 85 | 3 | 18667791 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 28259989 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 21521174 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 8274401 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 16511129 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 5.63e-08 | 4 | 85 | 3 | 34590152 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 7789999 | ||
| Pubmed | 1.25e-07 | 19 | 85 | 4 | 11342430 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 7737980 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 1.40e-07 | 5 | 85 | 3 | 21851338 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 1.40e-07 | 5 | 85 | 3 | 17064890 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 10672042 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 38788959 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 15212687 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 1.40e-07 | 5 | 85 | 3 | 16984997 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 18003893 | ||
| Pubmed | Evolution of the regulators of G-protein signaling multigene family in mouse and human. | 1.66e-07 | 51 | 85 | 5 | 11829488 | |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 2.80e-07 | 6 | 85 | 3 | 29107092 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 19273550 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 15860270 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 2.80e-07 | 6 | 85 | 3 | 26748576 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 2.80e-07 | 6 | 85 | 3 | 17255200 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 4.90e-07 | 7 | 85 | 3 | 34843575 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 22529366 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 33127481 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 19846565 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 12562828 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 16337335 | ||
| Pubmed | 5.59e-07 | 27 | 85 | 4 | 17077188 | ||
| Pubmed | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. | 6.50e-07 | 28 | 85 | 4 | 29212953 | |
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 33584538 | ||
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 20837989 | ||
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 9224647 | ||
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 33348080 | ||
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 10360839 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 1.67e-06 | 10 | 85 | 3 | 36313771 | |
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 3.05e-06 | 12 | 85 | 3 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 3.05e-06 | 12 | 85 | 3 | 28893949 | |
| Pubmed | 3.05e-06 | 12 | 85 | 3 | 8424456 | ||
| Pubmed | 3.05e-06 | 12 | 85 | 3 | 25774556 | ||
| Pubmed | 3.96e-06 | 13 | 85 | 3 | 11682476 | ||
| Pubmed | 3.96e-06 | 13 | 85 | 3 | 17062636 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 3.96e-06 | 13 | 85 | 3 | 15117747 | |
| Pubmed | 3.96e-06 | 13 | 85 | 3 | 24580729 | ||
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 5.03e-06 | 14 | 85 | 3 | 34400844 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 14871813 | ||
| Pubmed | Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance. | 5.90e-06 | 2 | 85 | 2 | 24074867 | |
| Pubmed | Gastroesophageal junction and gastroesophageal junction carcinoma : a short update. | 5.90e-06 | 2 | 85 | 2 | 28209106 | |
| Pubmed | Mfn2 is critical for brown adipose tissue thermogenic function. | 5.90e-06 | 2 | 85 | 2 | 28348166 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 30690319 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 31431479 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8573067 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16316347 | ||
| Pubmed | Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model. | 5.90e-06 | 2 | 85 | 2 | 30882371 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11514561 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 34600274 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 29212658 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17296794 | ||
| Pubmed | Mitofusin 1 is required for oocyte growth and communication with follicular somatic cells. | 5.90e-06 | 2 | 85 | 2 | 32281181 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15492289 | ||
| Pubmed | Local androgen inactivation in abdominal visceral adipose tissue. | 5.90e-06 | 2 | 85 | 2 | 14671194 | |
| Pubmed | MFN1 and MFN2 Are Dispensable for Sperm Development and Functions in Mice. | 5.90e-06 | 2 | 85 | 2 | 34948301 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 30873819 | ||
| Pubmed | AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer. | 5.90e-06 | 2 | 85 | 2 | 16338060 | |
| Interaction | AKR1C4 interactions | 3.45e-06 | 8 | 81 | 3 | int:AKR1C4 | |
| Cytoband | 19q13.41 | 7.77e-09 | 78 | 85 | 6 | 19q13.41 | |
| Cytoband | 10p15-p14 | 1.22e-07 | 6 | 85 | 3 | 10p15-p14 | |
| Cytoband | 4p16.3 | 1.98e-05 | 85 | 85 | 4 | 4p16.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | 6.05e-05 | 222 | 85 | 5 | chr4p16 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | MYH14 ZNF665 ZNF540 ZNF611 ZNF816 ZNF534 ZNF480 ZNF766 ZNF701 | 3.66e-04 | 1192 | 85 | 9 | chr19q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 6.41e-04 | 90 | 85 | 3 | chr10p15 | |
| Cytoband | 10q26.13 | 2.28e-03 | 38 | 85 | 2 | 10q26.13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF141 ZNF732 ZNF718 ZNF665 ZNF92 ZNF540 ZNF611 ZNF816 ZNF195 ZNF429 ZNF534 ZNF480 ZNF766 ZNF701 ZNF860 ZNF85 ZNF519 ZNF595 ZNF441 | 2.25e-12 | 718 | 63 | 19 | 28 |
| GeneFamily | Regulators of G-protein signaling | 8.52e-09 | 21 | 63 | 5 | 720 | |
| GeneFamily | Aldo-keto reductases | 1.78e-05 | 15 | 63 | 3 | 399 | |
| GeneFamily | Myosin heavy chains | 1.78e-05 | 15 | 63 | 3 | 1098 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 3.40e-03 | 25 | 63 | 2 | 994 | |
| GeneFamily | NLR family | 3.40e-03 | 25 | 63 | 2 | 666 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_UP | 5.04e-07 | 150 | 83 | 7 | MM936 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 2.29e-06 | 188 | 83 | 7 | MM1071 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 5.10e-06 | 36 | 83 | 4 | MM3660 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 5.70e-06 | 37 | 83 | 4 | MM630 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 1.17e-05 | 337 | 83 | 8 | M13206 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 2.02e-05 | 17 | 83 | 3 | MM826 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 2.33e-05 | 107 | 83 | 5 | M4913 | |
| Coexpression | MARSON_FOXP3_TARGETS_DN | 3.98e-05 | 60 | 83 | 4 | MM847 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 5.91e-05 | 24 | 83 | 3 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 6.70e-05 | 25 | 83 | 3 | MM480 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 6.91e-05 | 69 | 83 | 4 | MM621 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 9.08e-05 | 450 | 83 | 8 | M39072 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | 9.66e-05 | 584 | 83 | 9 | M39068 | |
| Coexpression | PODAR_RESPONSE_TO_ADAPHOSTIN_UP | 1.09e-04 | 148 | 83 | 5 | M16336 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 1.14e-04 | 465 | 83 | 8 | M39066 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 1.17e-04 | 30 | 83 | 3 | MM853 | |
| Coexpression | LI_CISPLATIN_RESISTANCE_DN | 1.56e-04 | 33 | 83 | 3 | M10150 | |
| Coexpression | DESCARTES_ORGANOGENESIS_NUETROPHILS | 2.03e-04 | 36 | 83 | 3 | MM3668 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 2.11e-04 | 268 | 83 | 6 | M45696 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN | 2.11e-04 | 92 | 83 | 4 | M3672 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 2.26e-04 | 173 | 83 | 5 | M2385 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | 2.37e-04 | 389 | 83 | 7 | M39073 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 190 | 85 | 6 | ff3dec5b45c6ea9b5319fb51a0198c6773b7be26 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 190 | 85 | 6 | 4971857eac9af17d66d673ed2ab7072639f60a10 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 155 | 85 | 5 | 29c4e9947bb4f7e257ed5c3bcf21bd67f88d473f | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-05 | 156 | 85 | 5 | 7ece590fd8f29382e349dd0e5e016d2926aeb518 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early|bone_marrow / Manually curated celltypes from each tissue | 2.59e-05 | 182 | 85 | 5 | 1a755ea44daf8447a3a1c30de7fdb9c3888bcbde | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 2.73e-05 | 184 | 85 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 186 | 85 | 5 | d8d559daff4aeef334d403fde4e3ee2e4a6086d0 | |
| ToppCell | PBMC-Mild-Hematopoietic|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.02e-05 | 188 | 85 | 5 | e3d9919eafc6181d2145b9d36f47066d0e22a8bd | |
| ToppCell | LAM-Myeloid-DC|LAM / Condition, Lineage and Cell class | 3.02e-05 | 188 | 85 | 5 | b4140110c2f7d25fd8a0d2749e33e02003ac4bf2 | |
| ToppCell | PBMC-Mild-Hematopoietic|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.02e-05 | 188 | 85 | 5 | 6bd9317be8918da639254f4bdd432647c43ba9b1 | |
| ToppCell | LAM-Myeloid-DC|Myeloid / Condition, Lineage and Cell class | 3.42e-05 | 193 | 85 | 5 | f665cce40053ae5d6e28f9f70ddf78e8598c9514 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 3.51e-05 | 194 | 85 | 5 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | 10x5'-blood-Hematopoietic_Erythro-Mega-Megakaryocyte_early|blood / Manually curated celltypes from each tissue | 3.51e-05 | 194 | 85 | 5 | 63dea7d630962761a70aa88e720ee35c22cbc81a | |
| ToppCell | 10x5'-blood-Hematopoietic_Erythro-Mega|blood / Manually curated celltypes from each tissue | 3.51e-05 | 194 | 85 | 5 | d0e7d35b5086834929c4bd39d4c6719b2d5fc71e | |
| ToppCell | Control-Myeloid-DC2|Control / Condition, Lineage and Cell class | 3.69e-05 | 196 | 85 | 5 | 0ccc26c2811e4c8631e0abd8555b167ac1e7a982 | |
| ToppCell | mild-Platelet|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.87e-05 | 198 | 85 | 5 | 91ae3cc261d23ec3aa7656bbf3f13dcbfee262d2 | |
| ToppCell | severe-Platelet|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.96e-05 | 199 | 85 | 5 | abda45c709469181d8224ae66216ed18ec370fd2 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | NS-moderate-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.96e-05 | 199 | 85 | 5 | aa2b51940115c22768c0d7493b4b60d41df3f376 | |
| ToppCell | moderate-Epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.06e-05 | 200 | 85 | 5 | 095783c9b75113ae350c2d5fb1195d71b41fa695 | |
| ToppCell | NS-moderate-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.06e-05 | 200 | 85 | 5 | 85940b4bf7971b872469dea8b8d7a45bdeb2a909 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Cortical_neuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.06e-05 | 200 | 85 | 5 | 085060d148158f7d9e938b6c4a3700ccbb3bca15 | |
| ToppCell | COVID-19-COVID-19_Mild-Others|COVID-19_Mild / Disease, condition lineage and cell class | 4.06e-05 | 200 | 85 | 5 | ecf94be4bb961ec343471547f2ea327bc6f709f4 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-Platelet|COVID-19_Mild / Disease, condition lineage and cell class | 4.06e-05 | 200 | 85 | 5 | bf5e7a36d6ed44a30f906702b40ace3ecd423398 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 4.06e-05 | 200 | 85 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.06e-05 | 200 | 85 | 5 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-mDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 132 | 85 | 4 | f8e2ba53063007d7507f1837ad669b0e4333cd23 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 136 | 85 | 4 | 82d7f90ef2a63a3137c331efd68c036cd0db3ac1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 136 | 85 | 4 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 136 | 85 | 4 | 03e4e2353c23ceffde35b2d0aadd15299e3db09f | |
| ToppCell | Adult-Immune-dendritic_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.80e-04 | 147 | 85 | 4 | 7cc4f74dd7a86247db8dc049ed7eadeb53825a96 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c4-DNAJB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-04 | 148 | 85 | 4 | e73860f6b8021482f82b83ccd2b7e1dfd7d9e80b | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-04 | 149 | 85 | 4 | 2a7f71da51c85e04de2123164914122480e60d66 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.00e-04 | 151 | 85 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 152 | 85 | 4 | 87a7116d0064a6051bdf28ce1e48bfc168273e66 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.06e-04 | 60 | 85 | 3 | aa75fef294803ec6396c7d2c1f51d52bc4a5b43f | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.06e-04 | 60 | 85 | 3 | 069fbabfd0e48e5809ff01a026439fd0bd017779 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.10e-04 | 153 | 85 | 4 | df2130689e53748e820a5835fa396fe82a5d2c7c | |
| ToppCell | facs-Heart-RV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 153 | 85 | 4 | af0ae08ff35f8210268457e5e15bcbe5d1f46d67 | |
| ToppCell | facs-Heart-RV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 153 | 85 | 4 | 984a2d847f4376183fdbab7ebc77c1bf7d448f44 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 153 | 85 | 4 | c81a88d3f707487c511020d3960a1c41e706c6a0 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 155 | 85 | 4 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.26e-04 | 156 | 85 | 4 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-04 | 156 | 85 | 4 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 157 | 85 | 4 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | Control-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.32e-04 | 157 | 85 | 4 | 4803f601c1ba43260aa09172acc7964aac2c8ccf | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.38e-04 | 158 | 85 | 4 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.55e-04 | 161 | 85 | 4 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.55e-04 | 161 | 85 | 4 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.61e-04 | 162 | 85 | 4 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | Dendritic_Cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.68e-04 | 163 | 85 | 4 | 5fff3932c1c259010e3add7a3b2301df2fa37df1 | |
| ToppCell | Dendritic_Cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.87e-04 | 166 | 85 | 4 | fbeb74b98b58085de323f744b18d4a8f7b22d5d4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 166 | 85 | 4 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.93e-04 | 167 | 85 | 4 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-04 | 167 | 85 | 4 | 91b14df450bfb6a2b406c88f8c75cd51eeb9e82b | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.93e-04 | 167 | 85 | 4 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-04 | 167 | 85 | 4 | 0aa1973141a2437df24c9857cd50ff3dfc7673c0 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.00e-04 | 168 | 85 | 4 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-04 | 171 | 85 | 4 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-04 | 171 | 85 | 4 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.28e-04 | 172 | 85 | 4 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | cellseq-Immune-Hematopoietic-Megakaryocyte/Platelet-Megakaryocyte/Platelet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.28e-04 | 172 | 85 | 4 | d0c3fb48c61762dcefca858cf13c9da8eb6d0f5e | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 3.28e-04 | 172 | 85 | 4 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | cellseq-Immune-Hematopoietic-Megakaryocyte/Platelet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.28e-04 | 172 | 85 | 4 | eb2915165cab2660511e4b70c3a6d3ab2f770809 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-mDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-04 | 172 | 85 | 4 | cc0e2a45fa74ee19e41612c3615729462474003a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-04 | 173 | 85 | 4 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | URO-Myeloid-cDC1|URO / Disease, Lineage and Cell Type | 3.35e-04 | 173 | 85 | 4 | 57f4e9f39ef6e02dca76f3dd0b39a0871917ed5a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 173 | 85 | 4 | 73f858f2c45d19b9ec8d99ac02c91551790f670c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 173 | 85 | 4 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | severe_influenza-Neutrophil|World / disease group, cell group and cell class (v2) | 3.43e-04 | 174 | 85 | 4 | f9f07436b7d3f190800cd85d229f007032f391e1 | |
| ToppCell | Dendritic_Cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.50e-04 | 175 | 85 | 4 | 584290a51f9975782a5ac8c6ad67c778d8323f8c | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.58e-04 | 176 | 85 | 4 | f3bbe8c1a8d132705eac360cf531261271d84588 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.66e-04 | 177 | 85 | 4 | c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae | |
| ToppCell | Dendritic_Cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.74e-04 | 178 | 85 | 4 | 3a28103cf282cc3637d1875a3b4cd7ddf3207687 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-04 | 179 | 85 | 4 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 180 | 85 | 4 | b927e7380369da6f92ba23d96103519884b70595 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.90e-04 | 180 | 85 | 4 | 38490017dd590e3fcfa7e88d8d15235d55f90cf1 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-04 | 182 | 85 | 4 | 1d37c486173cc4629842893ddd5033987c04086f | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 4.06e-04 | 182 | 85 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-04 | 182 | 85 | 4 | aef67bdc6937b315522d39959e26c9b0acf7ab52 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-04 | 182 | 85 | 4 | 087c9f88daf08f5d688b728c2386f91f210d2255 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early|bone_marrow / Manually curated celltypes from each tissue | 4.15e-04 | 183 | 85 | 4 | 3cc9f3dc3bc4bde1d3408b0a6ba58e135a11036d | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 4.15e-04 | 183 | 85 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Dendritic_Cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.15e-04 | 183 | 85 | 4 | 499da89b4abe7b746e703cd1e5c56f9b1d97ac3c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 184 | 85 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.23e-04 | 184 | 85 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.23e-04 | 184 | 85 | 4 | e6bf826be31e1723e24c366fc5a1cee9b15589bc | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.23e-04 | 184 | 85 | 4 | 667846c422cfa27e949a24844a305df859cb6760 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 184 | 85 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.23e-04 | 184 | 85 | 4 | a6f8b42982ec0cf44b950a2cd9715d068eec4ecb | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 184 | 85 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.23e-04 | 184 | 85 | 4 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | mild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.23e-04 | 184 | 85 | 4 | 1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.23e-04 | 184 | 85 | 4 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.32e-04 | 185 | 85 | 4 | 7cf69717b88347833819c161ca89e751416f6c67 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.32e-04 | 185 | 85 | 4 | 3563dd39ec58d3273f95f5bb36b9ccdc0aafb63a | |
| ToppCell | Multiple_Sclerosis-Other-Platelet|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.32e-04 | 185 | 85 | 4 | 2e480dde7ecb2f88ff005f86ef732a1cf0209d45 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-04 | 185 | 85 | 4 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 4.32e-04 | 185 | 85 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| Drug | cyclopentanone | 4.67e-08 | 3 | 83 | 3 | ctd:C007201 | |
| Drug | 4-benzoylbenzoic acid | 4.67e-08 | 3 | 83 | 3 | ctd:C058818 | |
| Drug | cyclopentanol | 4.67e-08 | 3 | 83 | 3 | ctd:C016327 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 4.67e-08 | 3 | 83 | 3 | ctd:C530610 | |
| Drug | Pregnanes | 1.86e-07 | 4 | 83 | 3 | ctd:D011278 | |
| Drug | tetralol | 1.86e-07 | 4 | 83 | 3 | ctd:C019106 | |
| Drug | gliquidone | 1.86e-07 | 4 | 83 | 3 | ctd:C010969 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 1.86e-07 | 4 | 83 | 3 | ctd:C018156 | |
| Drug | cloxazolam | 1.86e-07 | 4 | 83 | 3 | ctd:C005522 | |
| Drug | Hydroxysteroids | 4.65e-07 | 5 | 83 | 3 | ctd:D006914 | |
| Drug | NSC86000 | 4.65e-07 | 5 | 83 | 3 | CID000257630 | |
| Drug | cresolphthalein | 4.65e-07 | 5 | 83 | 3 | ctd:C010092 | |
| Drug | acenaphthene-1-ol | 9.27e-07 | 6 | 83 | 3 | ctd:C023723 | |
| Drug | Estazolam | 9.27e-07 | 6 | 83 | 3 | ctd:D004949 | |
| Drug | Medazepam | 9.27e-07 | 6 | 83 | 3 | ctd:D008472 | |
| Drug | Glipizide | 9.27e-07 | 6 | 83 | 3 | ctd:D005913 | |
| Drug | 4-hydroxyequilenin-o-quinone | 1.62e-06 | 7 | 83 | 3 | ctd:C117714 | |
| Drug | zomepirac | 1.62e-06 | 7 | 83 | 3 | ctd:C020549 | |
| Drug | Nitrazepam | 2.58e-06 | 8 | 83 | 3 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 3.86e-06 | 9 | 83 | 3 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 3.86e-06 | 9 | 83 | 3 | ctd:D004092 | |
| Drug | octyl gallate | 5.50e-06 | 10 | 83 | 3 | ctd:C016627 | |
| Drug | Nizatidine [76963-41-2]; Up 200; 12uM; PC3; HT_HG-U133A | 7.52e-06 | 196 | 83 | 7 | 6305_UP | |
| Drug | Dihydroxydihydrobenzopyrenes | 7.55e-06 | 11 | 83 | 3 | ctd:D004101 | |
| Drug | chlordecone alcohol | 7.55e-06 | 11 | 83 | 3 | CID000013946 | |
| Drug | fenamic acid | 1.00e-05 | 12 | 83 | 3 | ctd:C001209 | |
| Drug | Phenolphthalein | 1.00e-05 | 12 | 83 | 3 | ctd:D020113 | |
| Drug | DMBA-3,4-dihydrodiol | 1.30e-05 | 13 | 83 | 3 | CID000050096 | |
| Drug | flunisolide | 1.30e-05 | 13 | 83 | 3 | ctd:C007734 | |
| Drug | alpha-methylcinnamic acid | 1.31e-05 | 2 | 83 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 1.31e-05 | 2 | 83 | 2 | DB07768 | |
| Drug | baccharin | 1.31e-05 | 2 | 83 | 2 | ctd:C012764 | |
| Drug | Dydrogesterone | 1.65e-05 | 14 | 83 | 3 | ctd:D004394 | |
| Drug | 1-acenaphthenol | 1.65e-05 | 14 | 83 | 3 | CID000022750 | |
| Drug | 5-alpha-Dihydroprogesterone | 1.65e-05 | 14 | 83 | 3 | ctd:D043582 | |
| Drug | Meclofenamic Acid | 1.65e-05 | 14 | 83 | 3 | ctd:D008469 | |
| Drug | benzo(a)pyrene-1,6-quinone | 3.06e-05 | 17 | 83 | 3 | ctd:C030233 | |
| Drug | formycin triphosphate | 3.60e-05 | 51 | 83 | 4 | CID000122274 | |
| Drug | myo-inositol | RGS8 IGF2R LPAR5 P2RY4 PIK3CA GNAO1 SMPD3 DSEL KLRG1 RGS2 RGS3 RGS10 | 3.65e-05 | 811 | 83 | 12 | CID000000892 |
| Drug | cloxazolam | 3.66e-05 | 18 | 83 | 3 | CID000002816 | |
| Drug | benzo(a)pyrene-3,6-quinone | 3.66e-05 | 18 | 83 | 3 | ctd:C018003 | |
| Drug | Ruthenium Compounds | 3.66e-05 | 18 | 83 | 3 | ctd:D017975 | |
| Drug | 5-dihydrodeoxycorticosterone | 3.93e-05 | 3 | 83 | 2 | ctd:C454687 | |
| Drug | oxcarbazepine | 4.34e-05 | 19 | 83 | 3 | ctd:C036006 | |
| Drug | benzo(a)pyrene-7,8-dione | 5.09e-05 | 20 | 83 | 3 | ctd:C076588 | |
| Drug | Chrysenes | 5.09e-05 | 20 | 83 | 3 | ctd:D002911 | |
| Drug | aluminum fluoride | 5.61e-05 | 268 | 83 | 7 | CID000002124 | |
| Drug | Flunitrazepam | 5.93e-05 | 21 | 83 | 3 | ctd:D005445 | |
| Drug | coniferaldehyde | 5.93e-05 | 21 | 83 | 3 | ctd:C075384 | |
| Drug | Dutasteride | 5.93e-05 | 21 | 83 | 3 | ctd:D000068538 | |
| Drug | benzene dihydrodiol | 6.84e-05 | 22 | 83 | 3 | CID000000418 | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; HL60; HT_HG-U133A | 6.91e-05 | 190 | 83 | 6 | 2465_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.12e-05 | 191 | 83 | 6 | 1080_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 7.75e-05 | 194 | 83 | 6 | 3774_DN | |
| Drug | tetrahydrodeoxycorticosterone | 7.84e-05 | 4 | 83 | 2 | ctd:C009413 | |
| Drug | DBD-H | 7.84e-05 | 4 | 83 | 2 | CID000131382 | |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 7.85e-05 | 23 | 83 | 3 | DB03461 | |
| Drug | medazepam | 8.95e-05 | 24 | 83 | 3 | CID000004041 | |
| Drug | Glycyrrhetinic Acid | 8.95e-05 | 24 | 83 | 3 | ctd:D006034 | |
| Drug | haloperidol | 9.53e-05 | 394 | 83 | 8 | CID000003559 | |
| Drug | Pregnanolone | 1.01e-04 | 25 | 83 | 3 | ctd:D011280 | |
| Drug | 9,10-phenanthrenequinone | 1.01e-04 | 25 | 83 | 3 | ctd:C005399 | |
| Drug | AC1LEMI8 | 1.28e-04 | 27 | 83 | 3 | CID000688651 | |
| Drug | farnesal | 1.30e-04 | 5 | 83 | 2 | ctd:C084519 | |
| Drug | LY 171555 | 1.73e-04 | 142 | 83 | 5 | CID000001257 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 1.95e-04 | 31 | 83 | 3 | ctd:C017228 | |
| Drug | AC1L93E5 | 1.95e-04 | 6 | 83 | 2 | CID000412383 | |
| Drug | 3-hydroxyhexobarbital | 1.95e-04 | 6 | 83 | 2 | CID000439898 | |
| Drug | VDM11 | 2.72e-04 | 7 | 83 | 2 | CID009887748 | |
| Drug | estazolam | 2.81e-04 | 35 | 83 | 3 | CID000003261 | |
| Disease | Neoplasms, Hormone-Dependent | 2.07e-08 | 3 | 82 | 3 | C0027661 | |
| Disease | Ambiguous Genitalia | 2.06e-07 | 5 | 82 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 2.06e-07 | 5 | 82 | 3 | C0033804 | |
| Disease | Hermaphroditism | 2.06e-07 | 5 | 82 | 3 | C0019269 | |
| Disease | Intersex Conditions | 2.06e-07 | 5 | 82 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 2.06e-07 | 5 | 82 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 7.18e-07 | 7 | 82 | 3 | C0036875 | |
| Disease | Charcot-Marie-Tooth disease type 2A2A (implicated_via_orthology) | 7.63e-06 | 2 | 82 | 2 | DOID:0110155 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 2A2B (implicated_via_orthology) | 7.63e-06 | 2 | 82 | 2 | DOID:0111557 (implicated_via_orthology) | |
| Disease | opioid abuse (biomarker_via_orthology) | 2.28e-05 | 3 | 82 | 2 | DOID:11206 (biomarker_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 2 (implicated_via_orthology) | 4.56e-05 | 4 | 82 | 2 | DOID:0050539 (implicated_via_orthology) | |
| Disease | Endometrial Carcinoma | 4.94e-05 | 72 | 82 | 4 | C0476089 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 5.77e-05 | 27 | 82 | 3 | C1112155 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 7.17e-05 | 29 | 82 | 3 | C1333990 | |
| Disease | bladder disease (biomarker_via_orthology) | 7.59e-05 | 5 | 82 | 2 | DOID:365 (biomarker_via_orthology) | |
| Disease | cortolone glucuronide (1) measurement | 1.14e-04 | 6 | 82 | 2 | EFO_0800552 | |
| Disease | primary pulmonary hypertension (is_marker_for) | 2.11e-04 | 8 | 82 | 2 | DOID:14557 (is_marker_for) | |
| Disease | Ventricular Dysfunction | 2.11e-04 | 8 | 82 | 2 | C0242973 | |
| Disease | HEPATOCELLULAR CARCINOMA | 2.71e-04 | 9 | 82 | 2 | 114550 | |
| Disease | Hepatocellular carcinoma | 2.71e-04 | 9 | 82 | 2 | cv:C2239176 | |
| Disease | migraine disorder | 4.86e-04 | 357 | 82 | 6 | MONDO_0005277 | |
| Disease | Endometrial Neoplasms | 5.72e-04 | 58 | 82 | 3 | C0014170 | |
| Disease | nephroblastoma (is_implicated_in) | 6.79e-04 | 14 | 82 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | Sclerocystic Ovaries | 7.08e-04 | 144 | 82 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 7.08e-04 | 144 | 82 | 4 | C0032460 | |
| Disease | Colorectal Carcinoma | 7.48e-04 | 702 | 82 | 8 | C0009402 | |
| Disease | response to methotrexate | 8.93e-04 | 16 | 82 | 2 | GO_0031427 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 1.27e-03 | 19 | 82 | 2 | C1333991 | |
| Disease | cystathionine measurement | 1.27e-03 | 19 | 82 | 2 | EFO_0010474 | |
| Disease | Liver Cirrhosis, Experimental | 1.40e-03 | 774 | 82 | 8 | C0023893 | |
| Disease | Malignant neoplasm of stomach | 1.51e-03 | 300 | 82 | 5 | C0024623 | |
| Disease | Prostatic Neoplasms | 1.64e-03 | 616 | 82 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.64e-03 | 616 | 82 | 7 | C0376358 | |
| Disease | colorectal carcinoma (is_implicated_in) | 1.70e-03 | 22 | 82 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | Nasopharyngeal carcinoma | 1.70e-03 | 22 | 82 | 2 | C2931822 | |
| Disease | influenza A (H1N1) | 1.85e-03 | 87 | 82 | 3 | EFO_1001488 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.02e-03 | 24 | 82 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | lateral orbital frontal cortex volume measurement | 2.02e-03 | 24 | 82 | 2 | EFO_0010312 | |
| Disease | breast cancer (implicated_via_orthology) | 2.20e-03 | 25 | 82 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | Degenerative polyarthritis | 2.24e-03 | 93 | 82 | 3 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 2.24e-03 | 93 | 82 | 3 | C0086743 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.37e-03 | 26 | 82 | 2 | C0009405 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.64e-03 | 206 | 82 | 4 | C0152013 | |
| Disease | response to quetiapine | 2.75e-03 | 28 | 82 | 2 | GO_0097335 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKEDDTNEFVSAVCW | 691 | Q8NHY2 | |
| TEEEAFSSKRCLEWF | 96 | Q92564 | |
| FTLNEEEDCFKALIW | 811 | Q8NHU2 | |
| ELFDAWLSQFCLEEK | 141 | Q9NW68 | |
| SVSKEIWLDFEDFCV | 626 | Q8N7X0 | |
| KVIFDIVDLCTTWEA | 136 | P42330 | |
| LICLETSANDFKWFE | 466 | Q86UQ4 | |
| EEQCLFSAWLSEKED | 566 | P11532 | |
| FICRIVDWKEDCNFA | 301 | Q8IYB7 | |
| TVCLDDTTVKFEIWD | 61 | P20339 | |
| KEFSEENVLFWLACE | 61 | O43665 | |
| SEENLEFWLACEDFK | 1096 | P49796 | |
| WIDKFCLDADVFVLV | 191 | Q8IWA4 | |
| LDCSAEWLDFLEKFS | 801 | P20585 | |
| CSAVEDFVVDIVKAW | 676 | Q5KSL6 | |
| EVRLCFESFSDELWK | 171 | Q9H1C0 | |
| ALEFLADKVVCTESW | 191 | P50391 | |
| KEISDILLFCWAFEQ | 901 | Q6VAB6 | |
| VAVEREEWKFDTLCD | 256 | P38919 | |
| EECWFPKATDKSFVE | 556 | Q7Z406 | |
| LECSFGLEEIFEAVW | 786 | Q9Y4D7 | |
| FISEKWFDVCDVHIS | 551 | Q8N119 | |
| EAVTVEIEFCVWDQF | 1121 | Q9C000 | |
| TRWCTDVFDKFISAD | 561 | O43301 | |
| LCPDWKAEVEEFSFI | 616 | Q9NY59 | |
| FVDCPDESWALKAIE | 41 | O00425 | |
| PCLELEFDWFSSVVK | 471 | P42336 | |
| SWIDKFCLDADVFVL | 211 | O95140 | |
| FWFPIFSEKACDELV | 566 | O00469 | |
| PFWDDISESAKDFIC | 241 | Q96NX5 | |
| SEVELDCWFDEDFKF | 21 | P51582 | |
| LKEINCFTATFEIWV | 246 | A8MW95 | |
| VEEKDWNSSLEFCLA | 91 | Q96E93 | |
| IAKENLDVFCEAWES | 496 | Q9UBT7 | |
| TFACESELEAEEWCK | 91 | Q6PKX4 | |
| CEDDWKAPLTISLFF | 136 | O76082 | |
| EIDSFVDACEWKVSD | 896 | Q8IZU8 | |
| VEFVFLLSEQWCLEK | 56 | Q8N815 | |
| DEECWFPKATDKTFV | 536 | P35580 | |
| WELDENETLIVSKFC | 106 | Q9BQA1 | |
| KLLRTSECDFVFEWE | 1776 | P11717 | |
| WICDKDFQTVLPSFE | 331 | Q96L03 | |
| LKSEFCEENIEFWLA | 101 | P41220 | |
| CEENIEFWLACEDFK | 106 | P41220 | |
| TEFSEENLEFWLACE | 76 | P57771 | |
| SKEEWFISVLIFCPE | 241 | Q8IYL2 | |
| LWFEKCIVEAENFEE | 831 | Q07890 | |
| KWIHCFEDVTAIIFC | 211 | P09471 | |
| WDEEKECFESLSKEC | 666 | P40692 | |
| KILFDTVDLCATWEA | 136 | Q04828 | |
| KILFDTVDLCATWEA | 136 | P52895 | |
| ERCDVETLEWSKNVF | 426 | Q9H6R3 | |
| EQFCKLSIFLAWDVD | 81 | A8MTZ7 | |
| FIFKEWCEVGADCIT | 556 | P51790 | |
| DEECWFPKATDKSFV | 536 | P35749 | |
| KDVAIEFSQEEWTCL | 11 | Q9H7R5 | |
| FKDVAIEFSPEEWKC | 6 | Q3SXZ3 | |
| FRDVAIEFSPEEWKC | 6 | Q8IYB9 | |
| VAIDFSQKEWECLDT | 11 | Q8NDQ6 | |
| FRDVKIEFSLEEWQC | 6 | Q03936 | |
| FEDVAINFTCEEWAL | 6 | Q8N8Z8 | |
| FRDVAIEFSPEEWKC | 6 | Q8TB69 | |
| KEDFANVIESCPFWA | 436 | Q86TZ1 | |
| TEFSEENIEFWIACE | 106 | Q9NS28 | |
| WEDFITCLKDQDLIF | 111 | Q8IV42 | |
| KEDDEWILVDFIDTC | 26 | Q96A56 | |
| LAEVLDESDTFWCFV | 541 | Q8TBP0 | |
| IVHCETEFCITKWEE | 416 | Q5GH76 | |
| SDVAIEFSQEEWKCL | 11 | Q76KX8 | |
| ALEFLADKVVCTESW | 191 | P0DQD5 | |
| VSCSEDGKVFFWDLV | 251 | Q9BRX9 | |
| FRDVAIEFSPEEWKC | 6 | Q15928 | |
| DVAIEFSQAEWKCLD | 31 | Q8WV37 | |
| FTDVAIEFSLEEWQC | 6 | Q86V71 | |
| FRDVAIEFSLAEWKC | 26 | Q8N823 | |
| FRDVAIEFSLKEWQC | 6 | Q03923 | |
| FRDVAIEFSLEEWKC | 26 | A6NHJ4 | |
| FRDVAIEFSQEEWKC | 76 | Q9NV72 | |
| FRDVAIEFSQEEWKC | 11 | Q5HY98 | |
| FRDVAIEFSPEEWKC | 6 | B4DXR9 | |
| FRDVAIEFSLEEWKC | 6 | O14628 | |
| LEEEESAFWCLVAIV | 726 | Q9BYX2 | |
| FRDVAIEFSLEEWKC | 26 | Q0VGE8 | |
| FVTKWLKTVCDVRFD | 556 | Q9P2D8 | |
| FAFEEPEFALCEDWT | 266 | Q86W24 | |
| LECEVSEDDANVKWF | 361 | Q00872 |